{"id":"https://openalex.org/W4411151237","doi":"https://doi.org/10.1080/10428194.2025.2506498","title":"Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma","display_name":"Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma","publication_year":2025,"publication_date":"2025-06-09","ids":{"openalex":"https://openalex.org/W4411151237","doi":"https://doi.org/10.1080/10428194.2025.2506498","pmid":"https://pubmed.ncbi.nlm.nih.gov/40488632"},"language":"en","primary_location":{"id":"doi:10.1080/10428194.2025.2506498","doi":"https://doi.org/10.1080/10428194.2025.2506498","is_oa":true,"landing_page_url":"https://doi.org/10.1080/10428194.2025.2506498","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/10428194.2025.2506498?needAccess=true","source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/10428194.2025.2506498?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028972209","display_name":"Meng-Hsuan Lin","orcid":"https://orcid.org/0009-0002-3004-8438","observed_orcids":["https://orcid.org/0009-0002-3004-8438"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meng-Hsuan Lin","raw_affiliation_strings":["School of Public Health, University of Michigan","School of Public Health, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":"https://orcid.org/0009-0002-3004-8438","affiliations":[{"raw_affiliation_string":"School of Public Health, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"School of Public Health, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jonathan Weiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Weiss","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062534813","display_name":"Tycel Jovelle Phillips","orcid":"https://orcid.org/0000-0003-2143-9672","observed_orcids":["https://orcid.org/0000-0003-2143-9672"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tycel J. Phillips","raw_affiliation_strings":["City of Hope","City of Hope, Pasadena, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]},{"raw_affiliation_string":"City of Hope, Pasadena, CA, USA","institution_ids":["https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004986778","display_name":"Dahlia Sano","orcid":"https://orcid.org/0000-0001-7305-768X","observed_orcids":["https://orcid.org/0000-0001-7305-768X"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dahlia Sano","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073509371","display_name":"Shannon A. Carty","orcid":"https://orcid.org/0000-0003-2286-8014","observed_orcids":["https://orcid.org/0000-0003-2286-8014"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon A. Carty","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109867093","display_name":"Ryan Wilcox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Wilcox","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043885981","display_name":"Monalisa Ghosh","orcid":"https://orcid.org/0000-0003-2260-8212","observed_orcids":["https://orcid.org/0000-0003-2260-8212"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monalisa Ghosh","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Iman Ahmed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Iman Ahmed","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028996533","display_name":"Victoria R. Nachar","orcid":"https://orcid.org/0000-0002-5906-4733","observed_orcids":["https://orcid.org/0000-0002-5906-4733"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria R. Nachar","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035376582","display_name":"David W. Hutton","orcid":"https://orcid.org/0000-0001-9677-1632","observed_orcids":["https://orcid.org/0000-0001-9677-1632"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Hutton","raw_affiliation_strings":["School of Public Health, University of Michigan","School of Public Health, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"School of Public Health, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043944883","display_name":"Yasmin H. Karimi","orcid":"https://orcid.org/0000-0003-2648-4448","observed_orcids":["https://orcid.org/0000-0003-2648-4448"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yasmin H. Karimi","raw_affiliation_strings":["Division of Hematology/Oncology, University of Michigan","Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":"https://orcid.org/0000-0003-2648-4448","affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5043944883"],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":null,"apc_paid":null,"fwci":1.945,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.87125388,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"66","issue":"10","first_page":"1850","last_page":"1862"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.1316000074148178,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mosunetuzumab","display_name":"mosunetuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.9419999718666077},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.996999979019165},{"id":"https://openalex.org/keywords/relapsed-refractory-follicular-lymphoma","display_name":"relapsed/refractory follicular lymphoma","score":0.9100000262260437},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8740000128746033},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.8199999928474426},{"id":"https://openalex.org/keywords/net-monetary-benefit","display_name":"net monetary benefit","score":0.9599999785423279},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8450000286102295},{"id":"https://openalex.org/keywords/t-cell-redirecting-therapy","display_name":"T-cell redirecting therapy","score":0.6309999823570251},{"id":"https://openalex.org/keywords/payer-perspective","display_name":"payer perspective","score":0.625}],"concepts":[{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.7813107371330261},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6691471934318542},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5546236038208008},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5490936040878296},{"id":"https://openalex.org/C2911194787","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"CAR T-cell therapy","level":5,"score":0.5215120911598206},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4894379675388336},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43393275141716003},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32745110988616943},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2360101342201233},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23259466886520386},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.12770435214042664},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.07990297675132751},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000094703","descriptor_name":"Cost-Effectiveness Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000094703","descriptor_name":"Cost-Effectiveness Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/10428194.2025.2506498","doi":"https://doi.org/10.1080/10428194.2025.2506498","is_oa":true,"landing_page_url":"https://doi.org/10.1080/10428194.2025.2506498","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/10428194.2025.2506498?needAccess=true","source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:40488632","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40488632","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/10428194.2025.2506498","doi":"https://doi.org/10.1080/10428194.2025.2506498","is_oa":true,"landing_page_url":"https://doi.org/10.1080/10428194.2025.2506498","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/10428194.2025.2506498?needAccess=true","source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Zero hunger","score":0.7099999785423279,"id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411151237.pdf","grobid_xml":"https://content.openalex.org/works/W4411151237.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1529386050","https://openalex.org/W2058056848","https://openalex.org/W2519603001","https://openalex.org/W2761173020","https://openalex.org/W2891543930","https://openalex.org/W2917537905","https://openalex.org/W2925270992","https://openalex.org/W2948047060","https://openalex.org/W2987996816","https://openalex.org/W3001288491","https://openalex.org/W3046970338","https://openalex.org/W3092484545","https://openalex.org/W3186991133","https://openalex.org/W4200248834","https://openalex.org/W4200626931","https://openalex.org/W4224046834","https://openalex.org/W4284987950","https://openalex.org/W4308370165","https://openalex.org/W4379966935","https://openalex.org/W4385334309","https://openalex.org/W4387949803","https://openalex.org/W4389248426","https://openalex.org/W4390706100","https://openalex.org/W4399285742","https://openalex.org/W4399701651","https://openalex.org/W4403709325","https://openalex.org/W4405044643"],"related_works":["https://openalex.org/W2147384423","https://openalex.org/W2140133829","https://openalex.org/W3214044795","https://openalex.org/W2069019573","https://openalex.org/W2154715506","https://openalex.org/W3115793789","https://openalex.org/W4281705095","https://openalex.org/W3188388304","https://openalex.org/W2028697669","https://openalex.org/W1806784671"],"abstract_inverted_index":{"T":[0],"cell":[1],"redirecting":[2],"therapies,":[3],"including":[4],"mosunetuzumab":[5],"(mosun),":[6],"axicabtagene":[7],"ciloleucel":[8],"(axi-cel),":[9],"and":[10,25,44,72,96],"tisagenlecleucel":[11],"(tisa-cel),":[12],"are":[13],"FDA-approved":[14],"for":[15],"relapsed":[16],"refractory":[17],"follicular":[18],"lymphoma":[19],"(FL)":[20],"in":[21,40],"the":[22],"3rd":[23],"line":[24],"beyond.":[26],"There's":[27],"no":[28],"head-to-head":[29],"clinical":[30,68],"trial":[31],"data":[32],"to":[33,57],"compare":[34],"their":[35],"effectiveness.":[36],"These":[37,101],"products":[38],"differ":[39],"administration,":[41],"hospitalization":[42],"requirements,":[43],"toxicity":[45],"profiles,":[46],"impacting":[47],"therapy":[48],"selection.":[49],"We":[50],"developed":[51],"a":[52,61,108],"Markov":[53],"model":[54],"spanning":[55],"one":[56],"10":[58,80],"years":[59,81],"from":[60,67],"US":[62],"payer":[63],"perspective,":[64],"using":[65],"parameters":[66],"trials,":[69],"quality":[70],"utilities,":[71],"billing":[73],"costs.":[74],"Our":[75],"base":[76],"case":[77],"analysis":[78],"over":[79],"showed":[82],"that":[83],"mosun":[84,104],"provided":[85],"$67,654":[86],"more":[87,98],"Net":[88],"Monetary":[89],"Benefit":[90],"(NMB)":[91],"per":[92,111],"patient":[93],"than":[94,99],"axi-cel":[95],"$111,709":[97],"tisa-cel.":[100],"findings":[102],"suggest":[103],"is":[105],"cost-effective":[106],"at":[107],"$150,000":[109],"willingness-to-pay":[110],"QALY.":[112]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}